BIOMARKER:

PDGFRA mutation

Entrez ID:

Related biomarkers:

‹

›

PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	ripretinib Sensitive: B - Late Trials	ripretinib Sensitive: B - Late Trials
PDGFRA mutation PDGFRA mutation	Gastric Cancer Gastric Cancer	PDGFRA mutation PDGFRA mutation	Gastric Cancer Gastric Cancer	imatinib Sensitive: B - Late Trials	imatinib Sensitive: B - Late Trials
PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	avapritinib Sensitive: C2 – Inclusion Criteria	avapritinib Sensitive: C2 – Inclusion Criteria
PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	imatinib Sensitive: C2 – Inclusion Criteria	imatinib Sensitive: C2 – Inclusion Criteria
PDGFRA mutation PDGFRA mutation	Non Small Cell Lung Cancer NSCLC	PDGFRA mutation PDGFRA mutation	Non Small Cell Lung Cancer NSCLC	nintedanib Sensitive: C3 – Early Trials	nintedanib Sensitive: C3 – Early Trials
PDGFRA mutation PDGFRA mutation	Non Small Cell Lung Cancer NSCLC	PDGFRA mutation PDGFRA mutation	Non Small Cell Lung Cancer NSCLC	Immunotherapy Sensitive: C3 – Early Trials	Immunotherapy Sensitive: C3 – Early Trials
PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	AZD1775 Sensitive: D – Preclinical	AZD1775 Sensitive: D – Preclinical
PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	AZD1775 + avapritinib Sensitive: D – Preclinical	AZD1775 + avapritinib Sensitive: D – Preclinical